Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Sprout Health vs Direct Meds

Two GLP-1 providers, one scoreboard. We put Sprout Health and Direct Meds head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 7 · Grade B

Sprout Health

Visit Sprout Health Full brief →

FDA warning letter, September 2025 — issued to Sprout Health Partners LLC dba Sprout Health. See the FDA's warning letter database.

vs
No. 31 · Grade B−

Direct Meds

Visit Direct Meds Full brief →

FDA warning letter, September 2025 — issued to directmeds.com, Inc. dba DirectMeds. See the FDA's warning letter database.

The verdict

Sprout Health takes this head-to-head.

Sprout Health scores 86 to 82 on our six-factor Brief Score — A compounded GLP-1 provider with four-week and annual offers, plus a separate tablet-and-injection program whose advertised prices differ.

That doesn't make Direct Meds a bad call — it's best for readers who want a needle-free oral or sublingual route on either molecule and an all-inclusive price with no separate membership — and who are comfortable that the figures are company-stated rather than checkout-verified. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
90
80
Supply Reliability
82
80
Transparency
88
78
Access Breadth
92
84
Clinical Oversight
78
83
Track Record
84
78
Sprout HealthBrief Score 86 · 82Direct Meds

Price, coverage & the tracker

Sprout HealthDirect Meds
Brief Score86/100 (B)82/100 (B−)
Semaglutide$149 every 4 weeks; annual plan $1,188 upfront ($99/mo equivalent). Separate GLP-1 landing page lists $299/mo$249/mo sublingual · $297/mo injectable — both billed monthly on a 3-month minimum commitment
Tirzepatide$199 every 4 weeks; annual plan $1,788 upfront ($149/mo equivalent). Separate GLP-1 landing page lists $349/mo$299/mo sublingual · $399/mo injectable — both billed monthly on a 3-month minimum commitment
CoverageNot disclosedNot publicly listed
Brand-name accessNot confirmed on the pages checkedCompounded only
Oral / sublingualYesYes
On the trackerNewnew to the tracker, no prior readingStableprice stable

Sprout Health: Homepage offers four-week billing or annual prepayment; a separate GLP-1 page lists higher monthly rates. Confirm the price and renewal terms attached to your offer.

Direct Meds: Prices are provider-listed figures, not checkout-confirmed totals. Confirm the prescribed product, billing term and required fees before paying.

● Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.